Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis

Published:2017-05-04 Issue:9 Volume:2 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Kimberly W. Taylor^ORCID,O’Sullivan John F.,Nath Anjali K.,Keyes Michelle,Shi Xu,Larson Martin G.,Yang Qiong,Long Michelle T.^ORCID,Vasan Ramachandran,Peterson Randall T.,Wang Thomas J.,Corey Kathleen E.,Gerszten Robert E.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/92989/files/pdf

Reference46 articles.

1. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

2. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

3. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome

4. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis

5. Bi-directional analysis between fatty liver and cardiovascular disease risk factors

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics and Lipidomics for Studying Metabolic Syndrome: Insights into Cardiovascular Diseases, Type 1 & 2 Diabetes, and Metabolic Dysfunction-Associated Steatotic Liver Disease;Physiological Research;2024-08-31

2. Workplace food purchases, dietary intake, and gut microbial metabolites in a secondary analysis of the ChooseWell 365 study;The American Journal of Clinical Nutrition;2024-06

3. Plasma Metabolites and Life’s Simple 7 in REGARDS;Stroke;2024-05

4. BCAA-nitrogen flux in brown fat controls metabolic health independent of thermogenesis;Cell;2024-05

5. The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption;Nature Communications;2023-10-25